Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β

Effective treatment of metastatic renal cell carcinoma (RCC) remains a major medical concern, as these tumors are refractory to standard therapies and prognosis is poor. Although molecularly targeted therapies have shown some promise in the treatment of this disease, advanced RCC tumors often develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrella, Brenda L, Vincenti, Matthew P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544428/
https://www.ncbi.nlm.nih.gov/pubmed/23342250
http://dx.doi.org/10.1002/cam4.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544428/
https://www.ncbi.nlm.nih.gov/pubmed/23342250
http://dx.doi.org/10.1002/cam4.7

Ejemplares similares